Heramed Ltd

AU:HMD Australia Medical Devices
Market Cap
$28.96 Million
AU$46.77 Million AUD
Market Cap Rank
#25851 Global
#577 in Australia
Share Price
AU$0.04
Change (1 day)
-4.55%
52-Week Range
AU$0.01 - AU$0.05
All Time High
AU$0.32
About

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the … Read more

Heramed Ltd - Asset Resilience Ratio

Latest as of December 2024: 0.83%

Heramed Ltd (HMD) has an Asset Resilience Ratio of 0.83% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
AU$23.01K
Cash + Short-term Investments
Total Assets
AU$2.78 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Heramed Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Heramed Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$0.00 0%
Short-term Investments AU$23.01K 0.83%
Total Liquid Assets AU$23.01K 0.83%

Asset Resilience Insights

  • Limited Liquidity: Heramed Ltd maintains only 0.83% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Heramed Ltd Industry Peers by Asset Resilience Ratio

Compare Heramed Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
Medical Devices 0.01%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.26%
Double Medical Technology Inc
SHE:002901
Medical Devices 7.79%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
Medical Devices 6.64%
Shinhung
KO:004080
Medical Devices 4.17%
UMediC Group Berhad
KLSE:0256
Medical Devices 1.48%
Osang Healthcare Co.,Ltd
KQ:036220
Medical Devices 9.34%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%

Annual Asset Resilience Ratio for Heramed Ltd (2017–2024)

The table below shows the annual Asset Resilience Ratio data for Heramed Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.83% AU$23.01K AU$2.78 Million -0.63pp
2023-12-31 1.46% AU$29.38K AU$2.01 Million +0.92pp
2022-12-31 0.54% AU$22.51K AU$4.19 Million -0.01pp
2021-12-31 0.55% AU$25.27K AU$4.57 Million -0.68pp
2020-12-31 1.23% AU$39.06K AU$3.17 Million +0.22pp
2019-12-31 1.02% AU$36.61K AU$3.61 Million +0.85pp
2018-12-31 0.16% AU$6.86K AU$4.27 Million -0.24pp
2017-12-31 0.40% AU$5.00K AU$1.25 Million --
pp = percentage points